Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1964 Mar;43(3):444–452. doi: 10.1172/JCI104929

A Study of Creatine Metabolism in Diseases Causing Muscle Wasting *

Coy D Fitch 1,2,3, David W Sinton 1,2,3,
PMCID: PMC441937  PMID: 14135495

Full text

PDF
446

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANDERSON E., KEDDA L. H., KNOWLTON K. A preliminary investigation of the source of the creatinuria following transection of the spinal cord. Proc Soc Exp Biol Med. 1962 Aug-Sep;110:690–694. doi: 10.3181/00379727-110-27619. [DOI] [PubMed] [Google Scholar]
  2. BENEDICT J. D., KALINSKY H. J., SCARRONE L. A., WERTBEIM A. R., STETTEN D., Jr The origin of urinary creatine in progressive muscular dystrophy. J Clin Invest. 1955 Jan;34(1):141–145. doi: 10.1172/JCI103057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BOURDAKOS N., WOLF S. Creatine and muscular dystrophy. Relationship of creatine-creatinine metabolism to diet and drugs. Arch Neurol. 1962 Jun;6:439–450. doi: 10.1001/archneur.1962.00450240017003. [DOI] [PubMed] [Google Scholar]
  4. CONN R. B., Jr Fluorimetric determination of creatine. Clin Chem. 1960 Dec;6:537–548. [PubMed] [Google Scholar]
  5. COOPER A. C., MILLDR J. R. Progressive muscular dystrophy: a review. Rev Can Biol. 1962 Sep-Dec;21:337–351. [PubMed] [Google Scholar]
  6. DENNY-BROWN D. Degeneration of skeletal muscle. Rev Can Biol. 1962 Sep-Dec;21:507–522. [PubMed] [Google Scholar]
  7. DINNING J. S., FITCH C. D. Creatine metabolism in vitamin E deficiency. Proc Soc Exp Biol Med. 1958 Jan;97(1):109–111. doi: 10.3181/00379727-97-23660. [DOI] [PubMed] [Google Scholar]
  8. FITCH C. D., OATES J. D., DINNING J. S. The metabolism of creatine-1-C14 by mice with hereditary muscular dystrophy. J Clin Invest. 1961 May;40:850–856. doi: 10.1172/JCI104319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. LEE Y. C., VISSCHER M. B. On the state of creatine in heart muscle. Proc Natl Acad Sci U S A. 1961 Sep 15;47:1510–1515. doi: 10.1073/pnas.47.9.1510. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. MACKENZIE C. G., du VIGNEAUD V. Biochemical stability of the methyl group of creatine and creatinine. J Biol Chem. 1950 Jul;185(1):185–189. [PubMed] [Google Scholar]
  11. MILHORAT A. T. Creatine and creatinine metabolism and diseases of the neuromuscular system. Res Publ Assoc Res Nerv Ment Dis. 1953;32:400–421. [PubMed] [Google Scholar]
  12. PERKOFF G. T., SILBER R., TYLER F. H., CARTWRIGHT G. E., WINTROBE M. M. Studies in disorders of muscle. XII. Myopathy due to the administration of therapeutic amounts of 17-hydroxycorticosteroids. Am J Med. 1959 Jun;26(6):891–898. doi: 10.1016/0002-9343(59)90211-6. [DOI] [PubMed] [Google Scholar]
  13. RONZONI E., WALD S., BERG L., RAMSEY R. Distribution of high energy phosphate in normal and dystrophic muscle. Neurology. 1958 May;8(5):359–368. doi: 10.1212/wnl.8.5.359. [DOI] [PubMed] [Google Scholar]
  14. TANZER M. L., GILVARG C. Creatine and creatine kinase measurement. J Biol Chem. 1959 Dec;234:3201–3204. [PubMed] [Google Scholar]
  15. VAN PILSUM J. F., BOVIS M. Effect of various protein precipitants on recoveries of creatinine added to plasma. Clin Chem. 1957 Apr;3(2):90–94. [PubMed] [Google Scholar]
  16. VAN PILSUM J. F., HILLER B. On the proposed origin of creatinine from creatine phosphate. Arch Biochem Biophys. 1959 Dec;85:483–486. doi: 10.1016/0003-9861(59)90515-6. [DOI] [PubMed] [Google Scholar]
  17. VIGNOS P. J., Jr, WARNER J. L. GLYCOGEN, CREATINE, AND HIGH ENERGY PHOSPHATE IN HUMAN MUSCLE DISEASE. J Lab Clin Med. 1963 Oct;62:579–590. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES